Richard Burr: “I hope to solve 50 percent of the Fourth Circuit vacancies with a North Carolina solution.”

I will tell you right now, Congress is going to require accountability in the new program.

Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.

I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed.

Without Orrin, we wouldn't have a generic drug industry.